NY S06962

Requires insurance carriers and health plans to cover at least one abuse-deterrent opioid drug per active opioid ingredient on their formularies or drug lists.

Limits cost-sharing for brand name abuse-deterrent opioids to the lowest cost-sharing level applied to non-abuse deterrent brand name opioids under the same plan.

Limits cost-sharing for generic abuse-deterrent opioids to the lowest cost-sharing level applied to non-abuse deterrent generic opioids under the same plan.

Prohibits prior-authorization requirements or utilization review measures from requiring patients to use non-abuse deterrent opioids first before accessing abuse-deterrent opioid products.

Takes effect 120 days after enactment and applies to all policies and contracts issued, renewed, modified, altered or amended on or after that date.